Showcasing biopharma innovation in 2025, the 7th Exosome-Based Therapeutics Development Summit returns to Boston as the industry’s only dedicated forum covering the full exosome development pipeline, from discovery and optimized characterization to scalable manufacturing and clinical translation.

This year’s Summit brings together key players from Direct Biologics, Rion, Aegle Therapeutics, Aruna Bio, EXO Biologics, and more, as the field accelerates toward the first-ever exosome and EV approvals.

Across three content-packed days, you’ll gain actionable insights and strategic takeaways to support your journey from early-stage research to commercialization.

Join 80+ key exosome and extra-cellular vesicle experts specializing in Exosome Biology, R&D, CMC to Business Development for an unrivalled learning and networking opportunity to roadmap the therapeutic efficacy and delivery potential of exosomes and EVs towards commercialization and patients in need.

Don’t miss the chance to lead this field by driving breakthroughs in regenerative and precision medicine and position your pipeline for success in this rapidly advancing space.

Want to find out more? Download the Official 2025 Brochure here: https://ter.li/c1jk7p

To access tickets & discounts, follow this link: https://ter.li/pi0pdc